Fluoxetine Prevents Oligodendrocyte Cell Death by Inhibiting Microglia Activation after Spinal Cord Injury

Journal of Neurotrauma

Volumn 32, Issue 9, 2015, Pages 633-644

  Lee, Jee Y ^a   Kang, So R ^a   Yune, Tae Y ^a,b  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

fluoxetine; inflammation; microglia; oligodendrocyte; p38 MAPK

Indexed keywords

CASPASE 3; FLUOXETINE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELIN; NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR P75; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DEATH; CONTROLLED STUDY; DEMYELINATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MALE; MICROGLIA; MOUSE; NERVE FIBER; NONHUMAN; OLIGODENDROGLIA; SPINAL CORD INJURY; WHITE MATTER; ANIMAL; APOPTOSIS; C57BL MOUSE; DISEASE MODEL; DRUG ADMINISTRATION; DRUG EFFECTS; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE ACTIVATION; METABOLISM; PATHOLOGY; SPINAL CORD INJURIES;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FLUOXETINE; INJECTIONS, INTRAPERITONEAL; MACROPHAGE ACTIVATION; MALE; MICE, INBRED C57BL; MICROGLIA; NERVE GROWTH FACTOR; OLIGODENDROGLIA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SEROTONIN UPTAKE INHIBITORS; SPINAL CORD INJURIES;

EID: 84928713038     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2014.3527     Document Type: Article

References (48)

1. Liu, X.Z., Xu, X.M., Hu, R., Du, C., Zhang, S.X., McDonald, J.W., Dong, H.X., Wu, Y.J., Fan, G.S., Jacquin, M.F., Hsu, C.Y., and Choi, D.W. (1997). Neuronal and glial apoptosis after traumatic spinal cord injury. J. Neurosci. 17, 5395-5406.
2. Crowe, M.J., Bresnahan, J.C., Shuman, S.L., Masters, J.N., and Beattie, M. S. (1997). Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3, 73-76.
3. Popovich, P.G., Wei, P., and Stokes, B.T. (1997). Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377, 443-464.
4. Taoka, Y., Okajima, K., Uchiba, M., Murakami, K., Kushimoto, S., Johno, M., Naruo, M., Okabe, H., and Takatsuki, K. (1997). Role of neutrophils in spinal cord injury in the rat. Neuroscience 79, 1177-1182.
5. Teng, Y.D., Choi, H., Onario, R.C., Zhu, S., Desilets, F.C., Lan, S., Woodard, E.J., Snyder, E.Y., Eichler, M.E., and Friedlander, R.M. (2004). Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc. Natl. Acad. Sci. U. S. A. 101, 3071-3076.
6. Stirling, D.P., Khodarahmi, K., Liu, J., McPhail, L.T., McBride, C.B., Steeves, J.D., Ramer, M.S., and Tetzlaff, W. (2004). Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J. Neurosci. 24, 2182-2190.
7. Yune, T.Y., Lee, J.Y., Jung, G.Y., Kim, S.J., Jiang, M.H., Kim, Y.C., Oh, Y.J., Markelonis, G.J., and Oh, T.H. (2007). Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J. Neurosci. 27, 7751-7761.
8. Lee, J.Y., Choi, S.Y., Oh, T.H., and Yune, T.Y. (2012). 17beta-Estradiol inhibits apoptotic cell death of oligodendrocytes by inhibiting RhoA-JNK3 activation after spinal cord injury. Endocrinology 153, 3815-3827.
9. Chung, E.S., Chung, Y.C., Bok, E., Baik, H.H., Park, E.S., Park, J.Y., Yoon, S.H., and Jin, B.K. (2010). Fluoxetine prevents LPS-induced degeneration of nigral dopaminergic neurons by inhibiting microglia-mediated oxidative stress. Brain Res. 1363, 143-150.
10. Chung, Y.C., Kim, S.R., Park, J.Y., Chung, E.S., Park, K.W., Won, S.Y., Bok, E., Jin, M., Park, E.S., Yoon, S.H., Ko, H.W., Kim, Y.S., and Jin, B.K. (2011). Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation. Neuropharmacology 60, 963-974.
11. Lim, C.M., Kim, S.W., Park, J.Y., Kim, C., Yoon, S.H., and Lee, J.K. (2009). Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect. J. Neurosci. Res. 87, 1037-1045.
12. Lee, J.Y., Kim, H.S., Choi, H.Y., Oh, T.H. and Yune, T.Y. (2012). Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of blood-spinal cord barrier after spinal cord injury. Brain 135, 2375-2389.
13. Lee, J.Y., Lee, H.E., Kang, S.R., Choi, H.Y., Ryu, J.H., and Yune, T.Y. (2014). Fluoxetine inhibits transient global ischemia-induced hippocampal neuronal death and memory impairment by preventing blood-brain barrier disruption. Neuropharmacology 79, 161-171.
14. Hains, B.C., and Waxman, S.G. (2006). Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci. 26, 4308-4317.
15. Choi, D.C., Lee, J.Y., Moon, Y.J., Kim, S.W., Oh, T.H., and Yune, T.Y. (2010). Acupuncture-mediated inhibition of inflammation facilitates significant functional recovery after spinal cord injury. Neurobiol. Dis. 39, 272-282.
16. Hong, J., Cho, I.H., Kwak, K.I., Suh, E.C., Seo, J., Min, H.J., Choi, S.Y., Kim, C.H., Park, S.H., Jo, E.K., Lee, S., Lee, K.E., and Lee, S.J. (2010). Microglial Toll-like receptor 2 contributes to kainic acid-induced glial activation and hippocampal neuronal cell death. J. Biol. Chem. 285, 39447-39457.
17. Basso, D.M., Fisher, L.C., Anderson, A.J., Jakeman, L.B., McTigue, D.M., and Popovich, P.G. (2006). Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma 23, 635-659.
18. Tian, D.S., Dong, Q., Pan, D.J., He, Y., Yu, Z.Y., Xie, M.J., and Wang, W. (2007). Attenuation of astrogliosis by suppressing of microglial proliferation with the cell cycle inhibitor olomoucine in rat spinal cord injury model. Brain Res. 1154, 206-214.
19. Beattie, M.S. (2004). Inflammation and apoptosis: linked therapeutic targets in spinal cord injury. Trends Mol. Med. 10, 580-583.
20. Chen, K.B., Uchida, K., Nakajima, H., Yayama, T., Hirai, T., Watanabe, S., Guerrero, A.R., Kobayashi, S., Ma, W.Y., Liu, S.Y., and Baba, H. (2011). Tumor necrosis factor-a antagonist reduces apoptosis of neurons and oligodendroglia in rat spinal cord injury. Spine (Phila. Pa. 1976) 36, 1350-1358.
21. Bhat, N.R., Zhang, P., Lee, J.C., and Hogan, E.L. (1998). Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18, 1633-1641.
22. Dubreuil, C.I., Winton, M.J., and McKerracher, L. (2003). Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J. Cell Biol. 162, 233-243.
23. Li, Q.M., Tep, C., Yune, T.Y., Zhou, X.Z., Uchida, T., Lu, K.P., and Yoon, S. O. (2007). Opposite regulation of oligodendrocyte apoptosis by JNK3 and Pin1 after spinal cord injury. J. Neurosci. 27, 8395-8404.
24. Lee, J.Y., Chung, H., Yoo, Y.S., Oh, Y.J., Oh, T.H., Park, S., and Yune, T.Y. (2010). Inhibition of apoptotic cell death by ghrelin improves functional recovery after spinal cord injury. Endocrinology 151, 3815-3826.
25. Springer, J.E., Azbill, R.D., and Knapp, P.E. (1999). Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat. Med. 5, 943-946.
26. Yune, T.Y., Lee, J.Y., Cui, C.M., Kim, H.C., and Oh, T.H. (2009). Neuroprotective effect of Scutellaria baicalensis on spinal cord injury in rats. J. Neurochem. 110, 1276-1287.
27. Li, Y.Q., Jay, V., and Wong, C.S. (1996). Oligodendrocytes in the adult rat spinal cord undergo radiation-induced apoptosis. Cancer Res. 56, 5417-5422.
28. Warden, P., Bamber, N.I., Li, H., Esposito, A., Ahmad, K.A., Hsu, C.Y., and Xu, X.M. (2001). Delayed glial cell death following wallerian degeneration in white matter tracts after spinal cord dorsal column cordotomy in adult rats. Exp. Neurol. 168, 213-224.
29. Tekkok, S.B., and Goldberg, M.P. (2001). Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J. Neurosci. 21, 4237-4248.
30. Bianchi, M., Rossoni, G., Sacerdote, P., Panerai, A.E., and Berti, F. (1995). Effects of chlomipramine and fluoxetine on subcutaneous carrageenin-induced inflammation in the rat. Inflamm. Res. 44, 466-469.
31. Abdel Salam, O.M. (2004). Fluoxetine and sertraline stimulate gastric acid secretion via a vagal pathway in anaesthetised rats. Pharmacol. Res. 50, 309-316.
32. Dam, M., Tonin, P., De Boni, A., Pizzolato, G., Casson, S., Ermani, M., Freo, U., Piron, L., and Battistin, L. (1996). Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 27, 1211-1214.
33. Pariente, J., Loubinoux, I., Carel, C., Albucher, J.F., Leger, A., Manelfe, C., Rascol, O., and Chollet, F. (2001). Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann. Neurol. 50, 718-729.
34. Bao, F., and Liu, D. (2002). Peroxynitrite generated in the rat spinal cord induces neuron death and neurological deficits. Neuroscience 115, 839-849.
35. Min, K. J., Jou, I., and Joe, E. (2003). Plasminogen-induced IL-1beta and TNF-alpha production in microglia is regulated by reactive oxygen species. Biochem. Biophys. Res. Commun. 312, 969-974.
36. Li, W.W., Setzu, A., Zhao, C., and Franklin. R.J., (2005). Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J. Neuroimmunol. 158, 58-66.
37. Allen, S.J., Watson, J.J., Shoemark, D.K., Barua, N.U., and Patel, N.K. (2013). GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol. Ther. 138, 155-175.
38. Beattie, M.S., Harrington, A.W., Lee, R., Kim, J.Y., Boyce, S.L., Longo, F.M., Bresnahan, J.C., Hempstead, B.L., and Yoon, S.O. (2002). ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 36, 375-386.
39. Sun, F., Lin, C.L., McTigue, D., Shan, X., Tovar, C.A., Bresnahan, J.C., and Beattie, M.S. (2010). Effects of axon degeneration on oligodendrocyte lineage cells: dorsal rhizotomy evokes a repair response while axon degeneration rostral to spinal contusion induces both repair and apoptosis. Glia 58, 1304-1319.
40. Arnett, H.A., Mason, J., Marino, M., Suzuki, K., Matsushima, G.K., and Ting, J.P. (2001). TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 4, 1116-1122.
41. Carbonell, W.S., Murase, S., Horwitz, A.F., and Mandell. J.W. (2005). Migration of perilesional microglia after focal brain injury and modulation by CC chemokine receptor 5: an in situ time-lapse confocal imaging study. J. Neurosci. 25, 7040-7047. Erratum in: J. Neurosci. (2005). 25, table of contents.
42. Nicholas, R.S., Stevens, S., Wing, M.G., and Compston. D.A., (2002). Microglia-derived IGF-2 prevents TNFalpha induced death of mature oligodendrocytes in vitro. J. Neuroimmunol. 124, 36-44.
43. Yamashita, T., Higuchi, H., and Tohyama, M. (2002). The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho. J. Cell Biol. 157, 565-570.
44. Dergham, P., Ellezam, B., Essagian, C., Avedissian, H., Lubell, W.D., and McKerracher, L. (2002). Rho signaling pathway targeted to promote spinal cord repair. J. Neurosci. 22, 6570-6577.
45. Fournier, A.E., Takizawa, B.T., and Strittmatter, S.M. (2003). Rho kinase inhibition enhances axonal regeneration in the injured CNS. J. Neurosci. 23, 1416-1423.
46. Schucht, P., Raineteau, O., Schwab, M.E., and Fouad, K. (2002). Anatomical correlates of locomotor recovery following dorsal and ventral lesions of the rat spinal cord. Exp. Neurol. 176, 143-153.
47. Masson, R.L., Jr., Sparkes, M.L., and Ritz, L.A. (1991). Descending projections to the rat sacrocaudal spinal cord. J. Comp. Neurol. 307, 120-130.
48. Bracken, M.B. (1990). Methylprednisolone in the management of acute spinal cord injuries. Med. J. Aust. 153, 368.